Clinical Trial Update: Glycemic Holter Study (Continuous Glucose Monitoring) - [Phase 4]

View source ↗

Summary

Completed Phase 4 trial evaluating continuous glucose monitoring (glycemic Holter) in Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novartis | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED